$16.90
-0.09-0.53%
At Close: -
$16.90
00.00%
After Hours: 4:57 PM EDT
15 minutes delayed
Comments
Loading...
Catalyst Pharmaceuticals
CPRXNASDAQ
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | CPRX | Catalyst Pharmaceuticals | FY | 2024 | ā | ā | ā | $455.00M | $475.00M | $460.53M | Get Alert |
| 02/28/2024 | CPRX | Catalyst Pharmaceuticals | FY | 2024 | ā | ā | ā | $455.00M | $475.00M | $463.19M | Get Alert |
| 11/08/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $390.00M | $395.00M | $389.14M | Get Alert |
| 08/09/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $380.00M | $390.00M | $380.21M | Get Alert |
| 06/01/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $375.00M | $385.00M | $380.85M | Get Alert |
| 05/10/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $375.00M | $385.00M | $381.54M | Get Alert |
| 03/15/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $375.00M | $385.00M | $380.33M | Get Alert |
| 02/07/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $214.00M | $214.00M | $210.36M | Get Alert |
| 02/07/2023 | CPRX | Catalyst Pharmaceuticals | FY | 2023 | ā | ā | ā | $375.00M | $385.00M | $337.63M | Get Alert |
| 02/07/2023 | CPRX | Catalyst Pharmaceuticals | Q4 | 2022 | ā | ā | ā | $61.00M | $61.00M | $56.84M | Get Alert |
| 11/09/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $205.00M | $210.00M | $205.03M | Get Alert |
| 08/09/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $195.00M | $205.00M | $200.85M | Get Alert |
| 05/10/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $195.00M | $205.00M | $199.99M | Get Alert |
| 03/16/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $195.00M | $205.00M | $198.45M | Get Alert |
| 02/07/2022 | CPRX | Catalyst Pharmaceuticals | Q4 | 2021 | ā | ā | ā | $38.00M | $38.00M | $36.85M | Get Alert |
| 02/07/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2021 | ā | ā | ā | $141.00M | $141.00M | $138.30M | Get Alert |
| 02/07/2022 | CPRX | Catalyst Pharmaceuticals | FY | 2022 | ā | ā | ā | $195.00M | $205.00M | $163.53M | Get Alert |
| 03/16/2020 | CPRX | Catalyst Pharmaceuticals | FY | 2020 | ā | ā | ā | $135.00M | $155.00M | $145.62M | Get Alert |
| 01/06/2020 | CPRX | Catalyst Pharmaceuticals | Q4 | 2019 | ā | ā | ā | $30.00M | $30.00M | $29.16M | Get Alert |
| 01/06/2020 | CPRX | Catalyst Pharmaceuticals | FY | 2019 | ā | ā | ā | $102.00M | $102.00M | $101.35M | Get Alert |
| 01/06/2020 | CPRX | Catalyst Pharmaceuticals | FY | 2020 | ā | ā | ā | $135.00M | $155.00M | $145.62M | Get Alert |
| 11/12/2019 | CPRX | Catalyst Pharmaceuticals | FY | 2019 | ā | ā | ā | $100.00M | $100.00M | $111.01M | Get Alert |
| 11/12/2019 | CPRX | Catalyst Pharmaceuticals | FY | 2020 | ā | ā | ā | $135.00M | $155.00M | $166.63M | Get Alert |
FAQ
What is the most recent guidance for Catalyst Pharmaceuticals (CPRX)?
There have been no specific sales or earnings guidance reported for Catalyst Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.